Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/ablMIYAKE, K; INOKUCHI, K; MIYAKE, N et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 6, pp 541-545, issn 0969-7128, 5 p.Article

Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanismsBENOUCHAN, Malika; DO NASCIMENTO, Filipe; PERRET, Gérard Y et al.International journal of oncology. 2006, Vol 28, Num 2, pp 457-462, issn 1019-6439, 6 p.Article

Emerging biotechnological strategies for non-viral antiangiogenic gene therapyCHUNXI LIU; NA ZHANG.Angiogenesis (London). 2012, Vol 15, Num 4, pp 521-542, issn 0969-6970, 22 p.Article

Endothelial progenitor cells' 'homing' specificity to brain tumorsMOORE, X.-L; LU, J; SUN, L et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 10, pp 811-818, issn 0969-7128, 8 p.Article

Ad5/3-9HIF-Δ24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentGUSE, K; DIACONU, I; RAJECKI, M et al.Gene therapy (Basingstoke). 2009, Vol 16, Num 8, pp 1009-1020, issn 0969-7128, 12 p.Article

Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micellesVACHUTINSKY, Yelena; OBA, Makoto; MIYATA, Kanjiro et al.Journal of controlled release. 2011, Vol 149, Num 1, pp 51-57, issn 0168-3659, 7 p.Article